SCHEMBL17757012

SCHEMBL17757012

C=CC[C@@H](C(=O)O)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 2/20 0.39
GRIK2 Q13002 2/20 0.39
CYP2C19 P33261 3/20 0.38
CPA1 P15085 1/20 0.38
TSHR P16473 2/20 0.33
CYP3A4 P08684 1/20 0.33
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP3 P08254 1/20 0.32
MMP7 P09237 1/20 0.32
ABCC4 O15439 1/20 0.31
MAPT P10636 1/20 0.31
DPP4 P27487 1/20 0.31
SLC6A2 P23975 1/20 0.30
SLC6A4 P31645 1/20 0.30
BLM P54132 1/20 0.30
SLC6A3 Q01959 1/20 0.30
MEN1 O00255 1/20 0.30
CYP2D6 P10635 1/20 0.30
NFKB1 P19838 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5420620 1.00 GRIK1 (0.39) GRIK1GRIK2CYP2C19CPA1TSHR
SCHEMBL9785440 1.00 GRIK1 (0.39) GRIK1GRIK2CYP2C19CPA1TSHR
SCHEMBL8731754 0.83 GRIK1 (0.37) GRIK1GRIK2CYP2C19CPA1
SCHEMBL16682787 0.82 ALDH1A1 (0.32) GRIK1GRIK2CYP2C19CPA1MMP1
SCHEMBL11000169 0.81 GRIK1 (0.36) GRIK1GRIK2CYP2C19CPA1TSHR
SCHEMBL3153113 0.81 GRIK1 (0.36) GRIK1GRIK2CYP2C19CPA1
SCHEMBL9785500 0.79 GRIK1 (0.31) GRIK1MAPT
SCHEMBL8587066 0.79 GRIK1 (0.31) GRIK1MAPT
SCHEMBL16908675 0.77 CYP2C19 (0.42) GRIK1GRIK2CYP2C19CPA1TSHR
SCHEMBL16908693 0.77 CYP2C19 (0.42) GRIK1GRIK2CYP2C19CPA1ABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170342094-A1 HETEROARYL INHIBITORS OF PDE4 Tetra Discovery Partners, LLC 2017-11-30 US disclosed
US-9777024-B2 Heteroaryl inhibitors of PDE4 Tetra Discovery Partners, LLC (US) 2017-10-03 US disclosed
US-20160137672-A1 HETEROARYL INHIBITORS OF PDE4 Tetra Discovery Partners, LLC 2016-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170342094-A1 HETEROARYL INHIBITORS OF PDE4 PDE4A, PDE4B, PDE4C GRIK1 3746/4885GRIK2 3809/4885CYP2C19 1581/4885
US-20160137672-A1 HETEROARYL INHIBITORS OF PDE4 PDE4A, PDE4B, PDE4C GRIK1 3682/4885GRIK2 3843/4885CYP2C19 1357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.